Literature DB >> 10603959

Phosphorylation of the Thr17 residue of phospholamban. New insights into the physiological role of the CaMK-II pathway of phospholamban phosphorylation.

A Mattiazzi1, L Vittone, C Mundiña-Weilenmann, M Said.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 10603959     DOI： 10.1111/j.1749-6632.1998.tb08279.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  4 in total

1.  Role of CaMKII in Ang-II-dependent small artery remodeling.

Authors:  Anand M Prasad; Pimonrat Ketsawatsomkron; Daniel W Nuno; Olha M Koval; Megan E Dibbern; Ashlee N Venema; Curt D Sigmund; Kathryn G Lamping; Isabella M Grumbach
Journal:  Vascul Pharmacol       Date:  2016-09-20       Impact factor: 5.773

2.  Ser16-, but not Thr17-phosphorylation of phospholamban influences frequency-dependent force generation in human myocardium.

Authors:  Klara Brixius; Annette Wollmer; Birgit Bölck; Uwe Mehlhorn; Robert H G Schwinger
Journal:  Pflugers Arch       Date:  2003-10-03       Impact factor: 3.657

3.  CaMKII inhibition in type II pneumocytes protects from bleomycin-induced pulmonary fibrosis by preventing Ca2+-dependent apoptosis.

Authors:  Christopher J Winters; Olha Koval; Shubha Murthy; Chantal Allamargot; Sara C Sebag; John D Paschke; Omar A Jaffer; A Brent Carter; Isabella M Grumbach
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-11-06       Impact factor: 5.464

4.  Phosphoproteomic analysis identifies phospho-Threonine-17 site of phospholamban important in low molecular weight isoform of fibroblast growth factor 2-induced protection against post-ischemic cardiac dysfunction.

Authors:  Janet R Manning; Aruna B Wijeratne; Brian B Oloizia; Yu Zhang; Kenneth D Greis; Jo El J Schultz
Journal:  J Mol Cell Cardiol       Date:  2020-08-25       Impact factor: 5.000
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.